In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strainsRita E. Chen, Michael Diamond, John M. Errico et al.|Nature|2021Cited by 262
Defining the risk of SARS-CoV-2 variants on immune protectionMarciela M. DeGrace, Robert M. Johnson, Elodie Ghedin et al.|Nature|2022Cited by 185
Immunogenicity and efficacy of XBB.1.5 rS vaccine against the EG.5.1 variant of SARS-CoV-2 in Syrian hamstersNadia Soudani, Adrianus C. M. Boon, Traci L. Bricker et al.|Journal of Virology|2024Cited by 7
Immunogenicity and efficacy of XBB.1.5 rS vaccine against EG.5.1 variant of SARS-CoV-2 in Syrian hamstersAdrianus C. M. Boon, Meredith E. Davis-Gardner, Nadia Soudani et al.|Research Square|2024Cited by 3